Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aneurysm III: Interprofessional Care

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

Angina II: Classification

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends and Outcomes in Technology-Assisted Total Knee Arthroplasty in the United States From 2020 to 2024.

Arthroplasty today·2026

Same author

Evaluating Virtual and Hybrid Mentorship in Orthopaedic Surgery: Perceived Benefits, Challenges, and Impacts in the Post-COVID Era.

JBJS reviews·2026

Same author

Utilization Trends and Surgical Outcomes of Technology-Assisted Total Hip Arthroplasty in the United States From 2014 Through 2024.

Arthroplasty today·2026

Same author

Evaluation of spin in systematic reviews and meta-analyses of Matrix-induced Autologous Cartilage Implantation (MACI).

The Knee·2026

Same author

Current and emerging therapies for knee osteoarthritis: From conventional approaches to machine learning and stem cell innovations.

Regenerative therapy·2026

Same author

The Role of Race and Ethnicity on Time to Treatment in Orthopaedic Oncology.

Cancers·2026

Same journal

Comparative Effectiveness and Safety of Interventions for Atrial Fibrillation in Heart Failure: A Network Meta-Analysis of Randomized Trials.

Cardiovascular therapeutics·2026

Same journal

Integrated Network Pharmacology and Experimental Validation Approach to Systematically Elucidate the Cardioprotective Mechanisms of Shengmai Injection.

Cardiovascular therapeutics·2026

Same journal

Prasugrel: Reassessing Its Role in Contemporary Antiplatelet Therapy.

Cardiovascular therapeutics·2026

Same journal

Correction to "Association of Initial Laxative Strategy With Clinical Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Cohort Study".

Cardiovascular therapeutics·2026

Same journal

Baseline Ejection Fraction as a Modifier of Beta-Blocker Therapeutic Effects in Post-Acute Coronary Syndrome Patients With Non-Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.

Cardiovascular therapeutics·2026

Same journal

The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In-Stent Restenosis.

Cardiovascular therapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

In-stent restenosis.

Michael S Kim¹, Larry S Dean

¹Division of Cardiology, University of Washington School of Medicine, Seattle, WA 98195-6116, USA. mshkim@u.washington.edu

Cardiovascular Therapeutics

|April 22, 2010

Summary

This summary is machine-generated.

Coronary stents improved cardiology, but in-stent restenosis persists. Managing drug-eluting stent restenosis is a key challenge, requiring ongoing research into new treatments like drug-coated balloons.

More Related Videos

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Related Experiment Videos

Last Updated: Jun 13, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Area of Science:

Interventional Cardiology
Cardiovascular Research
Biomedical Engineering

Background:

Coronary stents revolutionized cardiology by improving procedural success and reducing restenosis compared to balloon angioplasty.
Despite advancements, bare metal stent restenosis remains a significant issue.
Drug-eluting stents have lowered restenosis rates but introduced the challenge of managing drug-eluting stent restenosis in complex cases.

Purpose of the Study:

To review the evolution of coronary stenting and the persistent challenge of in-stent restenosis.
To discuss current therapeutic strategies for bare metal and drug-eluting stent restenosis.
To explore emerging technologies and future directions for managing restenosis.

Main Methods:

Literature review of coronary stent technology and restenosis management.
Analysis of clinical outcomes and challenges associated with bare metal and drug-eluting stents.
Discussion of evolving treatment paradigms and novel therapeutic approaches.

Main Results:

Coronary stents significantly improved outcomes over balloon angioplasty but did not eliminate restenosis.
Drug-eluting stents reduced restenosis but created new management challenges.
Optimal treatment for drug-eluting stent restenosis is still under investigation, with bare metal stent restenosis often treated with drug-eluting stents.

Conclusions:

In-stent restenosis, particularly following drug-eluting stent implantation, remains a critical clinical problem.
Further research is essential to define optimal therapies for drug-eluting stent restenosis.
Novel approaches, including drug-coated balloons and advanced stent designs, are promising for future restenosis management.